Status:

COMPLETED

Effects of Diacetylmorphine (DAM) on Brain Function and Stress Response

Lead Sponsor:

University Hospital, Basel, Switzerland

Collaborating Sponsors:

University of Bern

Conditions:

Opiate

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

The aims of the study are to investigate the effects of diacetylmorphin (heroin) on brain using functional magnetic resonance imaging (fMRI), coupled with measurements of cortisol concentrations and n...

Detailed Description

Background: Heroin dependence (HD) is a chronic relapsing brain disorder that is defined by a compulsion to seek and use heroin, and a loss of control in limiting intake. The prescription of diacetyl...

Eligibility Criteria

Inclusion

  • opioid dependence

Exclusion

  • other psychiatric disorders

Key Trial Info

Start Date :

March 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2012

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT01174927

Start Date

March 1 2010

End Date

February 1 2012

Last Update

October 15 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UPK

Basel, Basel, Switzerland, 4025